Nevirapine is Used for managing HIV-1 infection through once-daily administration. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Viramune on Jun 21, 1996. Another drug containing Nevirapine is Viramune Xr. 17 different companies have introduced drugs containing Nevirapine.
Nevirapine Patents
Given below is the list of patents protecting Nevirapine, along
with the drug name that holds that patent and the company name owning that
drug.
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Nevirapine's patents.
Latest Legal Activities on Nevirapine's Patents
Given below is the list recent legal activities going on the following patents of Nevirapine.
Activity
Date
Patent Number
Payment of Maintenance Fee, 8th Year, Large Entity
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Nevirapine Generic API Manufacturers
Several generic applications have been filed for Nevirapine. The first generic version for Nevirapine was by Cipla Ltd and was approved on May 22, 2012. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jan 14, 2019.
Given below is the list of companies who have filed for
Nevirapine generic, along with the locations of their manufacturing plants worldwide.
1. ALVOGEN
Alvogen Inc has filed for 2 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Alvogen.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
400MG
tablet, extended release
Discontinued
ORAL
N/A
Jul 10, 2015
100MG
tablet, extended release
Discontinued
ORAL
N/A
Nov 9, 2015
Manufacturing Plant Locations
New
Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.
Country
City
Firm Name
United States
Morristown
Alvogen, Inc
2. APOTEX
Apotex Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Apotex.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
400MG
tablet, extended release
Discontinued
ORAL
N/A
Apr 3, 2014
Manufacturing Plant Locations
New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country
City
Firm Name
United States
Weston
Apotex Corp.
Canada
Brantford
Apotex Pharmachem Inc.
Winnipeg
Apotex Fermentation Inc.
Etobicoke
Apotex, Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
Toronto
Apotex Inc.
India
Bangalore
Apotex Research Private Limited - Bioequivalence Centre
Bengaluru
Apotex Research Private Limited
Bangalore
Apotex Pharmachem India Pvt Ltd.
3. APOTEX INC
Apotex Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Apotex Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Discontinued
ORAL
N/A
May 22, 2012
Manufacturing Plant Locations
New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
Country
City
Firm Name
Canada
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
Toronto
Apotex Inc.
4. AUROBINDO
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Aurobindo.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
50MG/5ML
(reference standard)
suspension
Prescription
ORAL
AA
May 22, 2012
Manufacturing Plant Locations
New
Aurobindo's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
Sangareddy
Aurobindo Pharma Limited
Polepally, Mahaboob Nagar
Aurobindo Pharma Limited
Bachupally
Aurobindo Pharma Limited
United States
East Windsor
Aurobindo Pharma USA Inc
5. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
100MG
tablet, extended release
Discontinued
ORAL
N/A
Nov 23, 2016
400MG
tablet, extended release
Discontinued
ORAL
N/A
Feb 28, 2017
Manufacturing Plant Locations
New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
Sangareddy
Aurobindo Pharma Limited
Polepally, Mahaboob Nagar
Aurobindo Pharma Limited
Bachupally
Aurobindo Pharma Limited
United States
East Windsor
Aurobindo Pharma USA Inc
6. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Cipla.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
400MG
tablet, extended release
Discontinued
ORAL
N/A
Oct 15, 2015
50MG/5ML
suspension
Prescription
ORAL
AA
Aug 3, 2017
Manufacturing Plant Locations
New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country
City
Firm Name
India
Bengaluru
Cipla Limited
Bangalore
Cipla Ltd.
Vasco Da Gama
Cipla Limited
Pithampur, District Dhar
Cipla Limited
Mumbai
Cipla Limited
Raigad
Cipla Limited
Kurkumbh Village, Dist. Pune
Cipla, Ltd.
7. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Hetero Labs Ltd Iii.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
8. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Macleods Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
400MG
(reference standard)
tablet, extended release
Prescription
ORAL
AB
Oct 6, 2017
200MG
(reference standard)
tablet
Prescription
ORAL
AB
Jan 14, 2019
9. MICRO LABS LTD
Micro Labs Ltd has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Micro Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
10. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Mylan.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
400MG
tablet, extended release
Prescription
ORAL
AB
Oct 27, 2014
Manufacturing Plant Locations
New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country
City
Firm Name
United States
San Carlos
Mylan Pharmaceuticals Inc.
Rockford
Mylan Institutional, Inc.
Santa Barbara
Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Morgantown
Mylan Specialty, L.P.
Greensboro
Mylan Pharmaceuticals Inc
Saint Albans
Mylan Technologies, Inc.
Morgantown
MYLAN CONSUMER HEALTHCARE Inc.
India
Sinnar
Mylan Laboratories Limited
Aurangabad
Mylan Laboratories Limited (FDF-2)
Hosur
Mylan Laboratories Limited
Bangalore
Mylan Laboratories Limited
Hyderabad
Mylan Laboratories Limited
Sarigam
Mylan Laboratories Limited
Pithampur, District Dhar
Mylan Laboratories Limited
Anekal Taluk, Bangalore
Mylan Laboratories Limited
Canada
Etobicoke
Mylan Pharmaceuticals ULC
Ireland
Inverin
Mylan Teoranta
11. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Mylan Pharms Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
12. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Norvium Bioscience.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Discontinued
ORAL
N/A
May 22, 2012
100MG
tablet, extended release
Discontinued
ORAL
N/A
Nov 9, 2015
13. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Prinston Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Discontinued
ORAL
N/A
May 22, 2012
14. SANDOZ
Sandoz Inc has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Sandoz.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
400MG
tablet, extended release
Prescription
ORAL
AB
Apr 3, 2014
Manufacturing Plant Locations
New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country
City
Firm Name
Austria
Kundl
Sandoz GmbH
Langkampfen
Sandoz GmbH
United States
Princeton
Sandoz Inc
East Hanover
Sandoz Incorporated
Spain
Palafolls
Sandoz Industrial Products, S.A.
Les Franqueses Del Valles
Sandoz Industrial Products S.A.
India
Navi Mumbai
Sandoz Private Limited
15. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Strides Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG
tablet
Prescription
ORAL
AB
May 22, 2012
Manufacturing Plant Locations
New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country
City
Firm Name
United States
East Brunswick
Strides Pharma Inc.
Chestnut Ridge
Strides Pharma, Inc.
India
Bangalore
Strides Pharma Science Limited
Puducherry
Strides Pharma Science Limited
16. TECH ORGANIZED
Technology Organized Llc has filed for 3 different strengths of generic version for Nevirapine. Given below are the
details of the strengths of this generic introduced by
Tech Organized.
